Prostate Cancer
Optimization of tomotherapy treatment planning for patients with bilateral hip prostheses - Abstract
March 1, 2014
Initial experience with abiraterone acetate in patients with castration-resistant prostate cancer - Abstract
February 28, 2014
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: Results from the initial screening round of the IMPACT study - Abstract
February 28, 2014
Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: Comparison of PSA slope and nadir - Abstract
February 27, 2014
Molecular imaging of urogenital diseases - Abstract
February 27, 2014
Value of MRI in detection of extracapsular extension in prostate cancer: A prospective study comparing imaging and histology - Abstract
February 27, 2014
Suggestion for the prostatic fossa clinical target volume in adjuvant or salvage radiotherapy after a radical prostatectomy - Abstract
February 27, 2014
Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: Results of the European Compassionate-Use Programme - Abstract
February 27, 2014
Evaluation of D'Amico criteria for low-risk prostate cancer - Abstract
February 27, 2014
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: Long-term results from the MRC RT01 randomised controlled trial - Abstract
February 27, 2014
Immunotherapy for prostate cancer: Recent developments and future challenges - Abstract
February 26, 2014
Immigration factors and prostate cancer survival among Hispanic men in California: Does neighborhood matter? - Abstract
February 26, 2014
Prostate-specific antigen bounce following stereotactic body radiation therapy for prostate cancer - Abstract
February 26, 2014
Validation of nomograms predicting lymph node involvement in patients with prostate cancer undergoing extended pelvic lymph node dissection - Abstract
February 26, 2014
Nonalcoholic fatty liver disease is a negative risk factor for prostate cancer recurrence - Abstract
February 26, 2014